Ranbaxy Laboratories Limited
Quick facts
Marketed products
- ANTARA® (fenofibrate) · Cardiovascular
Fenofibrate activates peroxisome proliferator-activated receptor alpha (PPARα) to reduce triglycerides and increase HDL cholesterol.
Phase 1 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: